Scientific PUBLICATIONS

FILTER BY TOPIC

Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase ib Clinical Trial Targeting Healthy Young Women

10/12/2022

Vaccines

Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine candidate

08/09/2023

npj Vaccines

Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for anitvenom production

07/24/2023

Toxicon

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals

07/15/2023

Malaria Journal

Practical Considerations for Next-Generation Adjuvant Development and Translation

06/27/2023

Pharmaceutics: Designing and Developing the Next Generation of Vaccine Adjuvants

Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine

06/19/2023

Cell

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

05/11/2023

Infectious Diseases and Therapy

A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area

03/30/2023

PLOS Neglected Tropical Diseases

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

03/06/2023

Nature Communications

Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions

02/16/2023

npj Vaccines

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]